IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION
申请人:Bristol-Myers Squibb Company
公开号:EP3632919A1
公开(公告)日:2020-04-08
The present invention provides pharmaceutical compositions comprising an imidazothiadiazole or imidazopyridazine compound that is a PAR4 antagonist, a pharmaceutically acceptable carrier and another therapeutic agent.